Log inSign up
Anthony LoSasso
1,983 posts
Anthony LoSasso profile banner
@EconTony

Anthony LoSasso

@EconTony
Robert F. and Sylvia T. Wagner Professor of Public Affairs, University of Wisconsin-Madison, economist, husband, father, Cubs fan, Ironman
Chicago, IL
anthonylosasso.com
Joined October 2012
287
Following
1,538
Followers
RepliesRepliesRepostsRepostsMediaMedia

Log in or sign up for X

See what’s happening and join the conversation

Continue with phone
or
Log in with username or email
Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
  • @EconTony
    Anthony LoSasso
    @EconTony
    Aug 7
    Just landed after a quick flight to @fly2ohare. Now for the longest part of the trip: getting to the gate.
  • @EconTony
    Anthony LoSasso
    @EconTony
    Jul 20
    Many are calling for health care price controls. In @nytopinion, Lorens Helmchen and I argue that price controls rest on a heroic assumption: regulators can know the right price and keep it from being shaped by the industries regulated. The answer isn’t price by decree.
    nytimes.com
    Opinion | This Is Not the Answer to Soaring Health Care Costs
    A government bureaucrat doesn’t know how much your medicine or doctor’s visit should cost.
  • @EconTony
    Anthony LoSasso
    @EconTony
    Jun 18
    The editors of the @NEJM recently invoked Stalin's infamous agronomist Trofim Lysenko to warn of where the administration's proposed "political review" of NIH grants will lead. 🧵
    1
  • @EconTony
    Anthony LoSasso
    @EconTony
    Jun 16
    Maybe you've seen the PhRMA ad with the tall hospital executive named "Mark" telling staff to "markup" drug prices. But what's the program behind the gag? My new @Forbes piece on 340B: how a tiny 1992 safety-net program became an $81B opaque revenue mechanism most Americans have
    Why Pharma And Hospitals Are At Odds Over The 340B Program
    From forbes.com
  • @EconTony
    Anthony LoSasso
    @EconTony
    Jun 1
    What can a health economist tell you about peptide dosing or longevity stacks? Nothing. But I have thoughts on what the peptide moment says about risk, regulation, and who gets to decide. New in @medpagetoday:
    Opinion | Who’s to Say That Medication Is Too Risky?
    From medpagetoday.com
    1